Variant report

Variant	nsv8370
Chromosome Location	chr8:102620173-102626866
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:27)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:27 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr8:102619068..102621889-chr8:103209199..103211504,2	MCF-7	breast:
2	chr8:102618309..102622005-chr8:102635683..102639742,4	MCF-7	breast:
3	chr8:102619314..102627249-chr8:102640943..102646440,7	MCF-7	breast:
4	chr8:102503101..102510814-chr8:102611042..102623761,44	MCF-7	breast:
5	chr8:102497120..102519676-chr8:102608888..102627613,87	MCF-7	breast:
6	chr8:102590604..102593500-chr8:102619061..102620861,2	MCF-7	breast:
7	chr8:102620661..102623620-chr8:102631815..102633375,2	MCF-7	breast:
8	chr8:102594059..102599317-chr8:102614223..102621570,11	MCF-7	breast:
9	chr8:102527891..102529497-chr8:102619687..102621638,2	MCF-7	breast:
10	chr8:102524405..102527812-chr8:102618321..102621883,4	MCF-7	breast:
11	chr8:102368939..102370495-chr8:102621232..102623192,2	MCF-7	breast:
12	chr8:102525449..102527790-chr8:102621194..102623795,2	MCF-7	breast:
13	chr8:102329492..102331583-chr8:102621198..102623417,2	MCF-7	breast:
14	chr8:102624784..102626996-chr8:102628052..102630610,2	MCF-7	breast:
15	chr8:102618432..102620239-chr8:103613397..103615204,2	MCF-7	breast:
16	chr8:102618200..102620350-chr8:102623909..102626355,2	K562	blood:
17	chr8:102588119..102597900-chr8:102614552..102624670,18	MCF-7	breast:
18	chr8:102617550..102620194-chr8:102645723..102647723,2	MCF-7	breast:
19	chr8:102620271..102621973-chr8:102646232..102648776,2	MCF-7	breast:
20	chr8:102624611..102627024-chr8:102643155..102644680,2	MCF-7	breast:
21	chr8:102539558..102541965-chr8:102618200..102620922,2	MCF-7	breast:
22	chr8:102619702..102621730-chr8:103818248..103820356,2	MCF-7	breast:
23	chr8:102618937..102621907-chr8:102637698..102639886,2	MCF-7	breast:
24	chr8:102618200..102620350-chr8:102623909..102626355,2	K562	blood:
25	chr8:102481107..102483505-chr8:102620149..102622971,2	MCF-7	breast:
26	chr8:102599405..102601179-chr8:102618530..102620423,2	MCF-7	breast:
27	chr8:102626664..102629265-chr8:102631491..102634297,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000083307	chromatin interactions
ENSG00000253991	chromatin interactions
ENSG00000253669	chromatin interactions
ENSG00000254024	chromatin interactions

Extended variants
information (count: 293 )
Associated
traits (count: 114 )

Variant overlapped rSNPs/rCNVs (count:293 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs111816716	chr8:102620183-102620184	Weak transcription Enhancers Strong transcription Active TSS Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
2	rs183220120	chr8:102620258-102620259	Weak transcription Enhancers Strong transcription Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
3	rs377200504	chr8:102620285-102620286	Weak transcription Enhancers Strong transcription Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
4	rs186974847	chr8:102620312-102620313	Weak transcription Enhancers Strong transcription Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
5	rs190749943	chr8:102620339-102620340	Weak transcription Enhancers Strong transcription Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
6	rs556406188	chr8:102620350-102620351	Weak transcription Enhancers Strong transcription Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
7	rs114008922	chr8:102620432-102620433	Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
8	rs535650204	chr8:102620475-102620476	Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
9	rs112424954	chr8:102620481-102620482	Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
10	rs571052484	chr8:102620580-102620581	Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
11	rs572843730	chr8:102620589-102620590	Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
12	rs556829988	chr8:102620590-102620591	Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
13	rs78337775	chr8:102620604-102620605	Weak transcription Strong transcription Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
14	rs118094236	chr8:102620617-102620618	Weak transcription Strong transcription Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
15	rs144304297	chr8:102620645-102620646	Weak transcription Strong transcription Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
16	rs2507795	chr8:102620690-102620691	Weak transcription Strong transcription Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs562758618	chr8:102620691-102620692	Weak transcription Strong transcription Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
18	rs570852824	chr8:102620730-102620731	Weak transcription Strong transcription Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
19	rs150758949	chr8:102620763-102620764	Weak transcription Strong transcription Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
20	rs183376364	chr8:102620783-102620784	Weak transcription Strong transcription Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs371972746	chr8:102620799-102620800	Weak transcription Strong transcription Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
22	rs151330445	chr8:102620815-102620816	Weak transcription Strong transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
23	rs386728292	chr8:102620817-102620818	Weak transcription Strong transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
24	rs553001920	chr8:102620872-102620873	Weak transcription Strong transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
25	rs552222802	chr8:102620877-102620878	Weak transcription Strong transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs4734553	chr8:102620919-102620920	Weak transcription Strong transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs199589210	chr8:102620957-102620958	Weak transcription Strong transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs531582006	chr8:102620963-102620964	Weak transcription Strong transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs112170262	chr8:102620964-102620965	Weak transcription Strong transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs4734554	chr8:102620965-102620966	Weak transcription Strong transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs112567471	chr8:102620966-102620967	Weak transcription Strong transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs4734555	chr8:102620967-102620968	Weak transcription Strong transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs113650682	chr8:102620969-102620970	Weak transcription Strong transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs370323017	chr8:102620975-102620976	Weak transcription Strong transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs560623244	chr8:102620997-102620998	Weak transcription Strong transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs62517371	chr8:102620999-102621000	Weak transcription Strong transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs569343848	chr8:102621003-102621004	Weak transcription Genic enhancers Strong transcription Flanking Active TSS Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs201831692	chr8:102621005-102621006	Weak transcription Genic enhancers Strong transcription Flanking Active TSS Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs75081838	chr8:102621009-102621010	Weak transcription Genic enhancers Strong transcription Flanking Active TSS Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs568655989	chr8:102621032-102621033	Weak transcription Genic enhancers Strong transcription Flanking Active TSS Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs7820809	chr8:102621057-102621058	Weak transcription Genic enhancers Strong transcription Flanking Active TSS Enhancers	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs554179532	chr8:102621072-102621073	Weak transcription Genic enhancers Strong transcription Flanking Active TSS Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs4734556	chr8:102621082-102621083	Weak transcription Genic enhancers Strong transcription Flanking Active TSS Enhancers	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs539667619	chr8:102621092-102621093	Weak transcription Genic enhancers Strong transcription Flanking Active TSS Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs188064429	chr8:102621135-102621136	Weak transcription Genic enhancers Strong transcription Flanking Active TSS Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
46	rs12544314	chr8:102621149-102621150	Weak transcription Genic enhancers Strong transcription Flanking Active TSS Enhancers	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs544208207	chr8:102621192-102621193	Weak transcription Genic enhancers Strong transcription Flanking Active TSS Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
48	rs142303166	chr8:102621198-102621199	Weak transcription Genic enhancers Strong transcription Flanking Active TSS Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
49	rs574637302	chr8:102621248-102621249	Weak transcription Genic enhancers Strong transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs566192179	chr8:102621265-102621266	Weak transcription Genic enhancers Strong transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:114)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Ewing''s sarcoma	21437220	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Seminomas	18059402	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Pancreatic cancer	21811587	CNVD
Thyroid cancer	19087340	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	17603634	CNVD
Testicular cancer	18059402	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21509527	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Cancer	20164919	CNVD
abnormal development	18461090	CNVD
Oral cancer	21386901	CNVD
Uveal melanoma	21693616	CNVD
Langer-Giedion syndrome	22283845	CNVD
Cancer	21637783	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	20632083	CNVD
Breast cancer	19602461	CNVD
Cancer	22429812	CNVD
Endometrial cancer	22040021	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oral cancer	19627613	CNVD
Prostate cancer	21088497	CNVD
colon cancer	17210682	CNVD
Breast cancer	21264507	CNVD
Breast cancer	22028636	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	16751803	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Gastric cancer	17167181	CNVD
Colorectal cancer	19359472	CNVD
Breast cancer	16461572	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
head and neck squamous cell carcinoma	18028549	CNVD
Breast cancer	17001317	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Ewing''s sarcoma	17952124	CNVD
Urothelial carcinoma	21177765	CNVD
Lung cancer	18438408	CNVD
Breast cancer	16608533	CNVD
Metanephric adenoma	20802469	CNVD
Hepatocellular carcinoma	18803288	CNVD
Prostate cancer	18632612	CNVD
Glioblastoma multiforme	18628472	CNVD
Ovarian cancer	22174824	CNVD
Prostate cancer	16573809	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Cancer	21949371	CNVD
Non-small cell lung cancer	21829676	CNVD
Multiple myeloma	16461302	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Acute myeloid leukemia	21358987	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Adenocarcinoma	21044232	CNVD
Squamous cell cancer	20885788	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	16461572	CNVD
Breast cancer	21399628	CNVD
small cell lung cancer	20016488	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	17393978	CNVD
Burkitt''s lymphoma	18698080	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Bladder cancer	19088036	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17899364	CNVD
Acute myeloid leukemia	21251322	CNVD
Renal cell carcinoma	18765545	CNVD
Basal cell lymphoma	17170743	CNVD
Colorectal cancer	16774939	CNVD
Autosomal-dominant progressive external ophthalmoplegia	19664747	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	17260012	CNVD
Sezary syndrome	18413736	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Cancer	20164920	CNVD
Urothelial cell carcinoma	18451213	CNVD
Colorectal cancer	21645411	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Ovarian cancer	20844748	CNVD
Colorectal cancer	16912164	CNVD
Breast cancer	20409316	CNVD
Congenital anomalies of the kidney and urinary tract	20467480	CNVD
Breast cancer	21611746	CNVD
Prostate cancer	22341455	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
T-cell lymphomas	22341440	CNVD

Chromatin state (count:150 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:102552200-102620600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr8:102590600-102631600	Weak transcription	HUES6 Cell Line	embryonic stem cell
3	chr8:102590600-102635200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
4	chr8:102597400-102620600	Weak transcription	Colonic Mucosa	Colon
5	chr8:102612800-102623000	Weak transcription	H9 Cell Line	embryonic stem cell
6	chr8:102615000-102621600	Enhancers	Stomach Mucosa	stomach
7	chr8:102615200-102620400	Weak transcription	Esophagus	oesophagus
8	chr8:102615200-102623000	Weak transcription	HUES48 Cell Line	embryonic stem cell
9	chr8:102615800-102621400	Enhancers	Fetal Intestine Small	intestine
10	chr8:102616200-102623600	Weak transcription	Right Atrium	heart
11	chr8:102616800-102643800	Weak transcription	Gastric	stomach
12	chr8:102617000-102620200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
13	chr8:102617400-102620200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
14	chr8:102617400-102625800	Strong transcription	Breast Myoepithelial Primary Cells	Breast
15	chr8:102617600-102621000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
16	chr8:102618000-102620200	Strong transcription	Placenta Amnion	Placenta Amnion
17	chr8:102618000-102640800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
18	chr8:102618200-102620600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
19	chr8:102618400-102620600	Enhancers	Duodenum Mucosa	Duodenum
20	chr8:102618400-102620600	Enhancers	Rectal Mucosa Donor 31	rectum
21	chr8:102618600-102621200	Enhancers	Fetal Lung	lung
22	chr8:102618600-102621400	Enhancers	Fetal Intestine Large	intestine
23	chr8:102618800-102621200	Enhancers	Pancreas	Pancrea
24	chr8:102618800-102622600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
25	chr8:102619000-102620200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
26	chr8:102619000-102620400	Enhancers	HMEC	breast
27	chr8:102619000-102620800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
28	chr8:102619000-102622400	Weak transcription	H1 Cell Line	embryonic stem cell
29	chr8:102619200-102620800	Enhancers	HUVEC	blood vessel
30	chr8:102619200-102631800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
31	chr8:102619400-102620600	Enhancers	HepG2	liver
32	chr8:102619400-102620800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
33	chr8:102619600-102620800	Enhancers	Muscle Satellite Cultured Cells	--
34	chr8:102619600-102620800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
35	chr8:102619600-102622800	Weak transcription	HUES64 Cell Line	embryonic stem cell
36	chr8:102619600-102623200	Weak transcription	Placenta	Placenta
37	chr8:102619600-102631800	Weak transcription	iPS-20b Cell Line	embryonic stem cell
38	chr8:102619800-102621000	Weak transcription	Sigmoid Colon	Sigmoid Colon
39	chr8:102619800-102656200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
40	chr8:102620000-102620200	Flanking Active TSS	A549	lung
41	chr8:102620000-102620400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
42	chr8:102620000-102620400	Active TSS	Rectal Mucosa Donor 29	rectum
43	chr8:102620000-102620600	Enhancers	Osteobl	bone
44	chr8:102620000-102620800	Enhancers	NHEK	skin
45	chr8:102620000-102621400	Enhancers	Hela-S3	cervix
46	chr8:102620000-102625000	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
47	chr8:102620200-102620400	Active TSS	A549	lung
48	chr8:102620200-102620600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
49	chr8:102620200-102620600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
50	chr8:102620200-102627400	Weak transcription	Placenta Amnion	Placenta Amnion

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links